KERX

Keryx Biopharmaceuticals, Inc $3.36 as of 2018-12-21
This price data has stopped updating. The last bar is 2018-12-21, 2869 days ago — our data source no longer publishes KERX. Everything below is as of that date, not today.
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
-0.5%
Next 1 week
+1.2%
Next 1 month
+2.9%
Seasonality
Mildly positive window
Next 30 days (to Nov 28): +4.2% median, 56% of the last 18 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 60
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.06%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.12 +2.9% · Seasonal tilt -0.0%
$4M/day volume 57% volatility -26% 1-year -83% from ATH
52-week range · 25% of the way up · -44% from the high
$2.47$5.98

Congressional trades in KERX Full tracker →

2 members · 4 buys / 1 sells · $5K–$75K disclosed · latest filing Aug 4, 2017.

BUY DS Debbie Wasserman Schultz · traded Dec 12, 2016 $1K–$15K
BUY DS Debbie Wasserman Schultz · traded Feb 10, 2017 $1K–$15K
BUY DS Debbie Wasserman Schultz · traded Dec 12, 2016 $1K–$15K
BUY DS Debbie Wasserman Schultz · traded Apr 27, 2016 $1K–$15K
SELL TM Thomas MacArthur · traded May 27, 2015 $1K–$15K

Not investment advice.